Literature DB >> 15118214

Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program.

Kenji Okada1, Kohji Ueda, Kazunori Morokuma, Yoichiro Kino, Ken Tokugawa, Sankei Nishima.   

Abstract

In Japan, mass vaccination for diphtheria, pertussis, and/or tetanus has been mandated by the Vaccination Law since 1948. In order to evaluate the efficacy of this vaccination policy, we conducted seroepidemiological studies on pertussis, diphtheria, and tetanus among individuals aged 0 - 80 years. The pertussis toxin seropositive rates of the vaccine-eligible groups and vaccine-ineligible groups were 55.0 and 57.9%, respectively. The seropositive rate of each group for diphtheria antitoxin was 76.3 and 75.7%, respectively. The tetanus antitoxin seropositive rates were 91.7 and 10.5%, respectively, showing a significant difference between the two groups (P < 0.001). For the three diseases, variations were seen between age groups in the geometric mean antibody titers due to changes of the vaccination program. The results of this study show that natural Bordetella pertussis infection has occurred more frequently than expected. In order to establish the most appropriate vaccination program for the control of pertussis, diphtheria, and tetanus in Japan, further evaluation is necessary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118214

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  5 in total

1.  Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Authors:  Aditi Kapasi; Bruce D Meade; Brian Plikaytis; Lucia Pawloski; Monte D Martin; Sandra Yoder; Michael T Rock; Séverine Coddens; Valérie Haezebroeck; Françoise Fievet-Groyne; Garvin Bixler; Charles Jones; Stephen Hildreth; Kathryn M Edwards; Nancy E Messonnier; Maria L Tondella
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

2.  Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Authors:  Dorothy Xing; Carl Heinz Wirsing von König; Penny Newland; Marion Riffelmann; Bruce D Meade; Michael Corbel; Rose Gaines-Das
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

3.  Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.

Authors:  Masanari Shiramoto; Shin Irie; Christine Juergens; Masako Yamaji; Satoshi Tamai; Masakazu Aizawa; Todd Belanger; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Authors:  Hyo-Jin Lee; Jung-Hyun Choi
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

Review 5.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.